Cory Schwartz

Company: iBio

Job title: Director, Research and Early Development

Bio:

Cory Schwartz, PhD, is Director of Drug Discovery at iBio, Inc., where he leads early-stage programs from target identification to candidate selection, leveraging AI-driven antibody discovery and strategic CRO partnerships. A skilled translational scientist, he bridges cutting-edge genome engineering with biologics development, having pioneered CRISPR-based metabolic engineering during his PhD at UC Riverside, where he developed high-throughput strain optimization platforms integrating NGS and bioinformatics.

Previously, as Senior Scientist at Pfenex Inc., Cory spearheaded their lead haematology program (PF901), designing screening cascades for single-domain antibodies and establishing automated hit-to-lead workflows. His expertise spans protein expression, antibody engineering, and AI-aided drug discovery, with a focus on accelerating biologics development through innovative platforms.

Seminars:

Roundtable Discussion: Implementing Flexible Dosing Schedules for Accommodating Patient Lifestyles to Improve Treatment Consistency for Better Long-Term Results 11:00 am

Offering once-weekly or monthly dosing options for reduced administration burden to enhance patient convenience for improved compliance Developing personalized dosing algorithms for individual metabolic profiles to optimize therapeutic response for maximized weight loss efficacy Providing patient support programs for education and adherence coaching to address barriers to compliance for sustained treatment engagementRead more

day: Day Two

Next-Generation Obesity Therapeutics: Long-Acting Antibodies for Improved Quality of Weight Loss 1:30 pm

Evaluating how the long-acting nature of next-generation antibodies improves patient adherence and convenience, providing a clear advantage in sustaining long-term weight loss and ensuring superior patient outcomes Discussing how these antibodies are being engineered for improved tolerability and reduced side effects, offering a clear benefit in enhancing patient comfort and ensuring more durable treatment engagement…Read more

day: Day Two